| A discussion of the value and benefit of transrectal power Doppler sonography for detecting low-risk prostate cancers, "Beyond the Abstract," by J.-L. Sauvain, and E. Sauvain |
| Secondary circulating prostate cells predict biochemical failure in prostate cancer patients after radical prostatectomy and without evidence of disease - Abstract |
| Racial differences in social support and coping among family caregivers of patients with prostate cancer - Abstract |
| Prostate cancer risk in rre-diabetic men: A matched cohort study - Abstract |
| High dose rate brachytherapy as monotherapy for localised prostate cancer: A hypofractionated two-implant approach in 351 consecutive patients - Abstract |
| Real-time contrast-enhanced transrectal US-guided prostate biopsy: Diagnostic accuracy in men with previously negative biopsy results and positive MR imaging findings - Abstract |
| Can delayed time to referral to a tertiary level urologist with an abnormal PSA level affect subsequent Gleason grade in the opportunistically screened population? - Abstract |
| Sentinel lymph node dissection in more than 1200 prostate cancer cases: Rate and prediction of lymph node involvement depending on preoperative tumor characteristics - Abstract |
| Application and clinical benefits of degarelix, a GnRH antagonist, in the treatment of advanced prostate cancer, "Beyond the Abstract," by Neal D. Shore, MD, FACS |
| Statement by NIH Director Francis Collins on U.S. Supreme Court ruling on gene patenting |
| Breaking News: Can someone else patent your genes? No, according to a closely watched ruling from the U.S. Supreme Court Thursday morning |
| ASCO 2013 - Poster: Results from a phase I study of enzalutamide in combination with docetaxel in men with prostate cancer |
| ASCO 2013 - Poster: A phase II multicenter study of the investigational single agent orteronel (TAK-700) in non-metastatic castration-resistant prostate cancer (nmCRPC [M0]) and rising prostate-specific antigen (PSA) |
| Radiotherapy with rectangular fields is associated with fewer clinical failures than conformal fields in the high-risk prostate cancer subgroup: Results from a randomized trial - Abstract |
| Sperm banking is of key importance in patients with prostate cancer - Abstract |
| Patients undergoing radical prostatectomy have a better survival than the background population - Abstract |
| Identification of comorbidities that place men at highest risk of death from androgen deprivation therapy before brachytherapy for prostate cancer - Abstract |
| Classifying the reasons men consider to be important in prostate-specific antigen (PSA) testing decisions: Evaluating risks, lay beliefs, and informed decisions - Abstract |
| Plan of the day selection for online image-guided adaptive post-prostatectomy radiotherapy - Abstract |
| Current role of surgery for high risk prostate cancer - Abstract |
| Cost-benefit of incorporating the detection of circulating prostate cells in a screening programme for prostate cancer - Abstract |
| Platinum-based chemotherapy for variant castrate-resistant prostate cancer - Abstract |
| Functional and molecular imaging of localized and recurrent prostate cancer - Abstract |
| PSA screening and deaths from prostate cancer after diagnosis-A population based analysis - Abstract |
| Discussing uncertainty and risk in primary care: Recommendations of a multi-disciplinary panel regarding communication around prostate cancer screening - Abstract |
| Molecular aspects of androgenic signaling and possible targets for therapeutic intervention in prostate cancer - Abstract |
<td style="font-family: |
